# reload+after+2024-01-20 15:43:20.370006
address1§Iconic Offices, The Greenway
address2§Block C Ardilaun Court St Stephens Green
city§Dublin
zip§112-114
country§Ireland
phone§353 0 166 99020
website§https://www.amarincorp.com
industry§Drug Manufacturers—General
sector§Healthcare
longBusinessSummary§Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
fullTimeEmployees§365
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Thomas Charles Reilly', 'age': 51, 'title': 'Chief Financial Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 856491, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Steven B. Ketchum Ph.D.', 'age': 58, 'title': 'President of Research & Development and Chief Scientific Officer', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 991187, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Aaron D. Berg', 'age': 60, 'title': 'Executive VP & President of U.S.', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 913703, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Patrick  Holt', 'title': 'President, CEO & Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jordan  Zwick', 'age': 36, 'title': 'Senior VP of Corporate Business Development & Investor Relations', 'yearBorn': 1987, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jonathan N. Provoost', 'title': 'Executive VP and Chief Legal & Compliance Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Donna  Pasek', 'title': 'Senior Vice President of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Laurent  Abuaf', 'title': 'President of Europe & Senior VP', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Nabil  Abadir', 'title': 'Chief Medical Officer of Global Medical Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. David  Keenan Ph.D.', 'title': 'Executive VP of Technical Operations & President of Europe', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§2.115
priceToSalesTrailing12Months§1.0896043
currency§USD
dateShortInterest§1702598400
forwardEps§-0.16
pegRatio§-0.13
exchange§NGM
quoteType§EQUITY
shortName§Amarin Corporation plc
longName§Amarin Corporation plc
firstTradeDateEpochUtc§733674600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§c9af6797-92a0-34d5-9138-8aac9b223625
gmtOffSetMilliseconds§-18000000
targetHighPrice§5.0
targetLowPrice§1.0
targetMeanPrice§2.31
targetMedianPrice§1.63
recommendationMean§3.2
recommendationKey§hold
numberOfAnalystOpinions§4
quickRatio§1.661
grossMargins§0.69237
ebitdaMargins§-0.06064
trailingPegRatio§None
